Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Investigator-Initiated Study Evaluating the Use of Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis

NCT07502339 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07502339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07502339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Investigator-Initiated Study Evaluating the Use of Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
December 1, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uc - ulcerative colitis